Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

MacroGenics Inc. buy Guggenheim

MacroGenics Inc.
Start price
€5.85
07.11.23 / 50%
Target price
€11.24
07.11.24
Performance (%)
-32.58%
End price
€3.94
08.11.24
Summary
This prediction ended on 08.11.24 with a price of €3.94. The BUY prediction by Guggenheim for MacroGenics Inc. performed very badly with a performance of -32.58%. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
MacroGenics Inc. 2.353% 2.353% 164.237%
iShares Core DAX® -0.874% 5.325% 6.865%
iShares Nasdaq 100 -0.381% 1.979% 25.696%
iShares Nikkei 225® -1.676% 1.952% 41.443%
iShares S&P 500 -0.655% 2.069% 21.405%

Comments by Guggenheim for this prediction

In the thread MacroGenics Inc. diskutieren
Prediction Buy
Perf. (%) -32.58%
Target price 11.238
Change
Ends at 07.11.24

MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $12.00 price target on the stock.
Ratings data for MGNX provided by MarketBeat

Guggenheim 
0
Report Share
07.11.23
In the thread Trading MacroGenics Inc.
Prediction Buy
Perf. (%) -32.58%
Target price 11.238
Change
Ends at 07.11.24

Die von Guggenheim gewählte maximale Laufzeit wurde überschritten

Guggenheim 
0
Report Share
08.11.24